FDA:5
again:2
declines:2
approval:2
of:12
Nabrivas:3
antibiotic:4
for:8
urinary:4
tract:4
infections:4
Reuters:3
Discover:1
Thomson:3
ReutersFinancialGovernment:1
SolutionsLegalReuters:1
News:1
AgencyRisk:1
Management:1
SolutionsTax:1
AccountingBlog:1
Answers:1
OnInnovation:1
ReutersDirectory:1
sitesLoginContactSupportBusinessMarketsWorldPoliticsTVMoreUnited:1
States:3
Health:1
NewsJune:1
20:1
2020:2
852:1
AM:1
2:1
days:1
agoFDA:1
infections2:1
Min:1
ReadReuters:1
The:3
US:1
Food:1
and:6
Drug:1
Administration:1
declined:2
to:11
approve:2
Nabriva:4
Therapeutics:1
Plcs:1
complicated:2
citing:1
stillunresolved:1
manufacturing:4
issues:2
the:19
biopharmaceutical:1
company:3
said:5
on:1
Friday:1
in:6
a:6
statement:2
that:2
complete:2
response:1
letter:1
from:3
resubmission:1
new:3
drug:3
application:2
Contepo:3
injection:1
cited:1
observations:2
at:3
companys:1
partners:2
could:1
not:3
be:3
resolved:2
due:1
FDAs:2
inability:1
conduct:1
onsite:1
inspections:2
because:1
travel:1
restrictions:1
coronavirus:1
outbreak:1
did:2
request:2
any:2
clinical:1
data:1
raise:1
other:1
concerns:1
with:3
regard:1
safety:1
or:1
efficacy:1
In:2
April:1
last:1
year:1
had:1
asking:1
address:1
relating:1
deficiencies:1
one:1
its:1
contract:2
manufacturers:1
general:1
previously:1
identified:1
product:1
quality:1
facility:2
inspection:1
related:1
our:1
are:1
required:1
satisfactorily:1
before:1
NDA:1
may:1
approved:1
chemically:1
known:1
as:1
fosfomycin:1
is:1
first:2
intravenously:1
administered:1
class:1
antibiotics:1
called:1
epoxide:1
United:2
Fosfomycin:1
was:1
discovered:1
1969:1
has:1
been:1
used:1
treat:1
variety:1
serious:1
bacterial:1
including:1
countries:1
outside:1
it:1
plans:2
meeting:1
discuss:1
next:1
steps:1
completing:1
foreign:1
Reporting:1
by:2
Kanishka:1
Singh:1
Bengaluru:1
Editing:1
Leslie:1
AdlerOur:1
StandardsThe:1
Trust:1
PrinciplesTrending1366:1
576narrowbrowserandphonemediumbrowserandportraittabletlandscapetabletmediumwidebrowserwidebrowserandlargermediumbrowserandlandscapetabletmediumwidebrowserandlargerabovephoneportraittabletandaboveaboveportraittabletlandscapetabletandabovelandscapetabletandmediumwidebrowserportraittabletandbelowlandscapetabletandbelowAppsNewslettersAdvertise:1
UsAdvertising:1
GuidelinesCookiesTerms:1
UsePrivacyAll:1
quotes:1
delayed:1
minimum:1
15:1
minutes:1
See:1
here:1
list:1
exchanges:1
delays:1
All:1
Rights:1
Reserved:1
